Category: Health
Not all 1.3 million American adults with type-1 diabetes will be eligible to receive Sotagliflozin. The U.S. Food and Drug Administration (FDA) advisory panel, was reportedly divided over whether to recommend the approval for a type-1 diabetes treatment developed by biopharmaceutical firms – Lexicon Pharmaceuticals …
The on-demand supply service would be made available to any client of Clinigen that is running clinical trials. Global pharmaceutical and services firm Clinigen Group plc has recently announced that the Clinical Trial Service (CTS) business of the company has extended its European clinical trial …
Sosei Group Corp. has reportedly stated that the firm has been notified by its partner AstraZeneca of a milestone achieved in clinical development with AZD4635, its next-generation immuno-oncology candidate, making it eligible to receive a payment of $15 million from AstraZeneca. For the uninitiated, AZD4635 …
Adlai Nortye Ltd., a global clinical-stage biopharmaceutical firm, has reportedly signed a clinical collaboration contract with Merck to assess the combination of AN0025 – an EP4 Antagonist by Adlai Nortye and KEYTRUDA® (pembrolizumab) an anti-PD-1 therapy by Merck. According to the terms of the contract, …
CellMax, a leading cancer diagnostics company, based in California, has reportedly announced that it has partnered with Medigen Biotech, in a bid to provide the latter with the CMxTM (its circulating tumor cell platform). Sources claim that Cellmax, through this partnership, aims to help Medigen …
Aurobindo Pharma USA Inc., an American unit of the India-based generic pharmaceuticals manufacturer, Aurobindo Pharma Ltd., is currently in the news for recalling around 80 lots of medicines used for treating heart failure and high blood pressure, from the U.S. market. The surprising move by …
The partnership will help serve the growing demand for cannabidiol and boost the rural economy of Arkansas. Fayetteville-based Arkansas Hemp Genetics LLC (AHG) has recently closed a partnership with the University of Arkansas, to grow, study and develop different hemp flowers for the budding cannabis …
South Korea based clinical stage biotech firm, Bridge Biotherapeutics Inc, has announced that the firm has been successful in activating clinical trial sites for Phase 2 study of a potential drug candidate for Ulcerative Colitis (UC) treatment, called BBT-401. Apparently, this Phase 2 clinical study …
